| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNMD | Common Stock | Options Exercise | $249,390 | +4,500 | +121% | $55.42 | 8,213 | 14 Mar 2025 | Direct | |
| transaction | CNMD | Common Stock | Tax liability | $253,910 | -4,316 | -53% | $58.83 | 3,897 | 14 Mar 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNMD | SARs (Stock Appreciation Rights) | Options Exercise | $0 | -4,500 | -100% | $0.000000 | 0 | 14 Mar 2025 | Common Stock | 4,500 | $55.42 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |